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              Abstract 
 
Introduction:Living donor kidney transplantation is the treatment of choice for patients with end stage kidney 
disease, which prevents chronic dialysis and its long term side effects. In addition to the detailed clinical history and 
thorough laboratory testing, anatomical assessment of kidneys, pre donation kidney volume and its function before 
transplantation are important factors to assess post transplant outcome. Materials and methods: Patients 
undergoing first renal transplant and those between age group of 18 to 60 years were included in the study. Donor 
kidney volume was measured ultrasonographically, from which donated kidney volume was calculated to evaluate 
GFR of the donated kidney from the total GFR of the donor. Estimation of recipient graft function was done using 
four variable abbreviated MDRD equation at 3, 6, 9 and 12 months post transplant. Results :Correlation of the 
donor age and donor kidney volume with recipients eGFR was done and the results were tabulated. Statistical 
analysis was done and correlations were seen with Pearson’s correlation coefficient. Statistical significance was 
defined as p value 0.05. Conclusion: Living donor kidney transplantation remains one of the vitally important 
treatment option for the end stage renal disease patients. Estimation of donor kidney volume, eGFR and donor age 
all together play an important role in post transplant graft survival and also better renal outcomes and functioning. 
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Introduction
Increasing incidence of End Stage Renal Disease 
worldwide is a matter of concern. Treatment option for 
these patients are haemodialysis and renal 
transplantation. Successful renal transplantation means 
both short and long term normal or near normal renal 
allograft function. Potent immunosuppressive regimens 
are now available to improve the short term renal 
allograft outcome [1]. But the long term graft survival 
remains suboptimal.  
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The quality of the donated organ kidney, its function 
before transplantation and the age of the donor have 
significant impact on the functioning of the grafted 
kidney. It has been hypothesised that the size and pre- 
transplant glomerular filtration rate ( GFR ) of a 
donated kidney influence post- transplant outcomes[2]. 
It has been seen that, renal grafts donated from male to 
female are far better than grafts from female to male. 
This has been attributed to differences in size, but 
without careful study of the direct size 
measurements[3]. Also some evidences suggest that 
higher pre-donation GFR correlates positively with 
post-transplant outcomes. 
 
This study is aimed at, to examine the association 
between donor kidney volume, donated kidney GFR 
and age of the donor with recipient’s eGFR at various 
months after live related renal transplantation. This will 
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help to judge the effectiveness of transplantation in 
both short and long term basis. 
 
Materials and Methods  
 
This is a prospective study, conducted between 
October 2019 to March 2020, for a period of one and  
half year. 53 live kidney donors and their recipients 
were studied . Cases included in this study were first 
renal transplant, recipients within the age group of 18 
to 60 years, willingness to participate as indicated by a 
signed written consent. Cases excluded were cadaveric 
transplant, unrelated donor and those not agreeing for 
transplantation. Detailed clinical history was taken and 
a thorough medical checkup was undertaken in each 
and every case. 
 
Measurement of donor kidney volume  
 
Donor kidney volume was measured by the Siemens 
P4 Ultrasound machine. This was conducted by 
experienced Radiologist.  
Length ( L ) was defined as maximum craniocaudal 
distance, Width ( W1 x W2 ) were defined as the 
maximum distance in between the two transverse 
dimensions.  
These parameters were measured 15 days before the 
due transplant date and the kidney volume was 
calculated as per the formula given below.  
 
V =  0.49 * L * W1 * W2 
 
Total kidney volume for each donor was taken as left 
kidney volume + right kidney volume  
 
Percentage of donated kidney volume =   
𝑇𝑟𝑎𝑛𝑠𝑝𝑙𝑎𝑛𝑡𝑒𝑑𝑘𝑖𝑑𝑛𝑒𝑦𝑣𝑜𝑙𝑢𝑚𝑒 ∗ 100
𝑇𝑜𝑡𝑎𝑙𝑘𝑖𝑑𝑛𝑒𝑦𝑣𝑜𝑙𝑢𝑚𝑒
 
 
Percentage of the donated kidney volume ( % DKV ) 
was taken in order to calculate the GFR of the donated 
kidney from the total GFR of the donor.  
The volume of the single transplanted kidney was then 
corrected for recipient body surface area ( BSA ) to 
calculate the corrected donated kidney volume. 
 
Corrected donated kidney volume  
= 
𝑑𝑜𝑛𝑎𝑡𝑒𝑑𝑘𝑖𝑑𝑛𝑒𝑦𝑣𝑜𝑙𝑢𝑚𝑒∗1.732
𝑅𝑒𝑐𝑖𝑝𝑖𝑒𝑛𝑡𝐵𝑆𝐴
 
 
 
This adjustment is needed in order to assess the effects 
of the transplanted graft volume in a particular 
recipient. 
Measurement of donor GFR  
Donor total GFR was measured by the 99m Tc- DTPA 
( diethylenetriamine pentaacetic acid ) two plasma 
sample method. DTPA GFR was then corrected for the 
donor body surface area and expressed as ml/ min/ 1.73 
m2. Donor GFR was also measured by the four variable 
Abbreviated MDRD Equation 15 days prior to the due 
transplant date.  
 
Estimation of recipient graft function 
Graft kidney function was measured by the four- 
variable Abbreviated MDRD Equation at 3 months, 6 
months, 9 months and 12 months post transplant. 
eGFR=186 ∗ (𝑆𝐶𝑟)−1.154 ∗ (𝑎𝑔𝑒)−0.203 ∗
0.742(𝑖𝑓𝑓𝑒𝑚𝑎𝑙𝑒) ∗ 1.212(𝑖𝑓𝐴𝑓𝑟𝑖𝑐𝑎𝑛 − 𝐴𝑚𝑒𝑟𝑖𝑐𝑎𝑛) 
 
Donor age, donated kidney GFR and corrected donated 
kidney volume were then correlated with the recipient 
estimated GFR at 3 months, 6 months, 9 months and 12 
months after the renal transplantation. 
 
Statistical analysis 
The recipient data was stratified as per the following 
parameters: 
 
1. Corrected donated kidney volume: < 90 mm3/ 
1.73 m2 vs≥ 90mm3/1.73 m2. 
2. Donated kidney GFR: < 40 ml / min / 1.73 m2 
vs ≥  40 ml / min/ 1.73 m2 
3. Donor age: < 45 years. vs ≥ 45 years  
 
 
Statistical analysis was performed by using software 
version 15. 0 ( Chicago,IL). Data were expressed as 
mean ± SD ( minimum-maximum ) or as n ( % ) when 
appropriate. Student t-test and / or ANOVA test to 
compare means for parametric data. Correlations were 
seen with Pearson’s correlation coefficient. To further 
characterise the effects of different donor variables and 
recipient factors on graft function at 3 months, 6 
months, 9 months and 12 months post transplantation 
we performed uni-variable and multi variable linear 
regression analysis. Statistical significance was defined 
as p- values < 0.05. 
This clinical study was approved by the Ethics 
Committee. 
 
Results  
 
A total number of 76 patients had undergone allogenic 
renal transplantation from October 2019 to March 2020 
in our institute. Out of these, 23 were excluded due to 
various reasons as per the exclusion criteria. Finally 53 
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patients of ESRD who underwent renal transplantation 
within the above mentioned period were included in 
the study. 
Basic diseases of the recipients included, presumed 
Chronic glomerulonephritis 34(0.64%), presumed 
Chronic interstitial nephritis13 (0.24%), diabetic 
nephropathy 04 (0.07%), lupus nephritis 01 ( 0.01% ), 
Adult polycystic Kidney disease01 ( 0.01%). HLA 
study of both the donor and recipients was done. HLA 
mismatch was calculated from four alleles of the HLA- 
A, HLA-B locus.( Figure-1). All these patients were on 
triple drug immunosuppressants. 45 (84.9%) were on 
Tacrolimus and 08 (15.1%) were on cyclosporine; 46 
(86.8%) patients were on MMF and 07 (13.2 %) 
patients were on Azathioprene. The dosage varied 
according to specific requirements. All patients had 
received steroids. 11 (20.8 %) patients received 
induction therapy with IL-2R receptor blockers (One 
case received Basiliximab and 10 received 
Daclizumab). 
 
The baseline recipient characteristics were noted down. 
Amongst the 53 cases studied, the overall age of the 
patients was 34 ± 10.6 years. There were 48 males with 
a mean age of 34.3 ± years and 05 females with a mean 
age of 31± 10. 2 years. The mean BSA of the recipients 
was 1.57± 0.13 kg / m2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-1: Number of HLA Mismatches (%) 
 
The baseline donor characteristics were listed. There 
were 15 male and 38 female donors. The overall mean 
age of the donors was 41.4 ± 11.9 years. The mean 
total GFR of the donors as calculated by the 99m Tc – 
DTPA ( diethylene triamine pentaacetic acid) two 
plasma sample method was 94 ±14.6 ml/ min / 1.73 m2. 
The mean donated kidney volume was 83.5 ± 14.8 
mm3. The mean of the percentage of the donated 
kidney volume was 50.2 ± 3.9%. The donor kidney 
volume corrected for recipient body surface area was 
93 ± 22.7 mm3. The donated kidney GFR was 47.3 ± 
8.6 ml/ min / 1.73 m2. Estimated GFR ( eGFR) of the 
recipient after transplantation was calculated by the 
Abbreviated MDRD 4 variable equation at 3, 6, 9 and 
12 months respectively after the renal transplantation. 
The mean eGFR at the end of 3 months was 84.6 ± 
23.4 ml/ min / 1.73 m2. It was 80.2 ± 20.5 ml/ min / 
1.73 m2 at the end of 6 months, 78.8 ± 21.3 ml/ min/ 
1.73 m2 at the end of 9 months and 77.8 ±  17. 6 ml / 
min / 1.73 m2 at the end of 12 months. ( Table-1 ). 
Correlation of the Corrected Donor Kidney Volume 
with the eGFR of the recipient was done, for which the 
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recipients were divided into two groups ( Figure-2). In 
group 1, there were 24 recipients having corrected 
kidney volume <  90 mm3 and in the group 2, there 
were 29 recipients, having corrected kidney volume ≥  
90 mm3. It was seen that the recipients in group 2 had 
better eGFR at 3 and 6 months, although the difference 
was not seen at 9 and 12 months. Correlation of the 
donated kidney GFR with eGFR of the recipients was 
noted down ( Figure-3 ). The mean donated kidney 
GFR was 47 ± 8.6 ml/ min/ 1.73 m2. In group 1, there 
were 17 recipients, who received donated kidney GFR 
of < 40 ml/ min/ 1.73 m2 and in group 2, there were 36 
recipients, who received donated kidney GFR ≥ 40 ml/ 
min / 1.73 m2. It was seen that the recipients in group 
2, had a significantly higher GFR at 6 months, but not 
thereafter. Correlation of the donor age with eGFR of 
the recipients showed ( where 33 recipients were 
having donor age under 45 and 20 recipients with 
donor age ≥ 45 years), no difference in the recipients 
eGFR at 6 and 9 months respectively, but there was a 
significant difference in the mean eGFR between the 
two age groups at 3 months and at the end of 12 
months ( 87.8 ± 20.4  vs 79.6 ± 27.4 ml/ min and 82.7 
± 16.8 ml/ min vs 71 ± 15.8 ml/ min) respectively. ( 
Figure-4 ) ( p = 0.049 and p= 0.04 ). 
 
Univariate analysis of factors associated with eGFR of 
the recipients at various months post transplant were 
tabulated. We found that recipient’s eGFR at 3 months 
was associated with the age of the donor and the 
corrected donor kidney volume. At 6 months, the 
recipient’s eGFR was associated with corrected donor 
kidney volume and donated kidney GFR. At 9 months, 
we could not find any association of the recipient GFR 
with the various donor factors. However, there was a 
negative association between the recipient eGFR at 12 
months with the age of the donor and a positive 
correlation with the percentage of the donated kidney 
volume.  In multivariate analysis, donor factors 
analysed were similar as that of univariate analysis. 
(Table - 2) 
 
Correlation of the recipient’s eGFR at various post 
transplant months with different parameters showed a 
negative correlation between the donor age and GFR of 
the recipient . 
At 3 and 12 months ( p= 0.02, 0.04 ) respectively, but 
failed to statistically correlate during 6 and 9 months 
post transplant. Corrected donor kidney volume was 
found to have a positive correlation with the recipients 
GFR at 3 months and 6 months, but not at 9 and 12 
months. Similarly the donor GFR correlated with the 
recipient GFR at 6 months, but not during the 
subsequent follow up. We also estimated the GFR of 
the donor by the four variable abbreviated Modification 
of Diet in Renal Disease (MDRD) equation. The results 
of both the mean estimated GFR and GFR done by 
DTPA methods were almost similar ( 99.5 ± 26.7 vs 94 
± 14 ml / min / 1.73 m2 ). Similarly mean donated 
kidney GFR by MDRD equation and DTPA method 
were 49.7 ± 12 vs 47.3 ± 8.6 ml/ min/ 1.73 m2. 
Table - 1 : Serial eGFR of the recipients during follow up 
Time period post transplant eGFR (ml/min/1.73 m2 ) 
At 3 months (n = 53) 84.63 ± 23.4 
At 6 months (n = 53)  80.2 ± 20.45 
At 9 months (n= 53)  78.82 ± 21.33 
At 12 months (n = 36) 77.80 ± 17.6 
 
 
Figure-2: Corrected DVR and e GFR 
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Figure-3: Donated Kidney GFR and eGFR at various post transplant Months 
 
Figure-4: Donar age and e GFR  
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Table - 2 : Univariate and Multivariate analysis of factors associated with eGFR of the recipient at various 
post transplant months 
3month Univariate ( ) P value  Mult. Var. ( ) 
D. age -0.543 0.049 0.024 
Sex 3.117 0.675 0.170 
%DKV 1.115 0.182 0.269 
Corr.DKV 0.303 0.033 0.016 
DKGFR 0.709 0.063 0.128 
6 month  Uni.var ( ) P value  Mult.var.(p) 
D.age -.309 0.196 0.695 
Sex 0.395 0.950 0.893 
%DKV 0.320 0.093 0.20 
Corrr.DKV 0.310 0.012 0.034 
DKGFR 1.003 0.002 0.004 
9 month  Uni.var ( ) P value  Multi.var.( p ) 
D.age -0.342 0.170  
Sex 6.9710.290   
%DKV 1.221 0.108  
Corr.DKV 0.127 0.336  
DKGFR 0.425 0.227  
12 month     
D.age -.538 0.027 0.056 
Sex 1.708 0.783 0.523 
%DKV 2.266 0.013 0.02 
Corr.DKV -3.00 0.840 0.129 
DKGFR 0.419 0.224 0.970 
Discussion  
Outcomes of renal transplantation depends on both 
immunological and non immunological factors. Among 
the non immunological factors, primary kidney disease 
and post transplant infections are extensively studied. 
Donor age plays an important role with recipient’s 
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eGFR. Kidney function declines progressively with 
age, leaving a tendency for other age related donor 
factors to exist with low GFR [4].The mean age of 
donors in the present study was 42.4 ± 11.9 years. We 
found a strong negative association between the donor 
age and the recipient GFR at 3 and 12 months.Our 
results are consistent with those of Poggio et al, who 
found that younger age of the donor was associated 
with higher GFR. The mean age of donors in their 
study was similar to that in our study 43 ±9 years. 
Further they found that recipients with donors aged less 
than 45 years had significantly better GFR at 6 months, 
one to two years post transplant [5].When we divided 
our recipients on the basis of the donor age into those < 
45 years ( group 1) and > 45 years ( group 2 ) we found 
that at the end of the study period at 12 months, the 
mean eGFR of recipients in group 1 was significantly 
better with a value of 82.7 ± 16.8 ml/ min/ 1.73m2vs 
71± 15 ml/ min/ 1.73 m2). In the Norwegian experience 
graft survival was about 65% after 4 years with older 
living donors versus 85% with younger donors[6]. The 
effect of donor age on patient survival persisted even 
when censoring recipients in whom grafts failed before 
death suggesting that both longevity and quality of 
graft function are important in patient survival[7]. The 
French cohort study also noted that baseline eGFR was 
associated with age, leading the authors to conclude 
that baseline values < 90 mL / min/1.73m2 are 
reasonable for older donors[8]. 
 
Recipients receiving larger corrected donated kidney 
volume have definitely better outcome. Those who 
received corrected kidney volume ≥ 90 mm3 had 
significantly higher GFR at 3 months ( 92 vs 76 ml/ 
min/ 1.73m2 ) and at 6 months ( 85 ml vs 74 ml/ min / 
1.73 m2) respectively. Our results are  consistent with 
those of Poggio et al, 2006 who also found a 
correlation between the measured kidney volume and 
GFR. However, they had taken a cut off of measured 
kidney volume as 120 mm3, which may be valid for 
western population where the body surface area is 
much larger in comparison to that of Indian population. 
With a smaller body surface area of our donors, a cut 
off of 90 mm3 should be valid. The mean body surface 
area of the donors in the study by Poggio et al was 1.86 
± 0.22 m2, in contrast to 1.55 ± 0.1m2 of our patients. 
Also majority of our donors were females ( 71% ) who 
had lower body surface area of 1.5 ± 0.18 m2 as 
compared to that of the recipients , majority of whom 
were males. So our donors had a smaller body surface 
area compared to our recipients. In a study of 54 live 
related renal transplantation, Saxsena et al also found a 
correlation of recipient GFR with donor kidney 
volume/ weight ratio at 6 and 12 months post 
transplant[3]. Douverny JV found that the kidney 
weight had a correlation with the donor’s BMI (r= 
0.43, p < 0.001) and with the Creatinine clearance at 12 
months ( r= 0.31, p= 0.001 ).  They concluded that 
kidney weight significantly influences the Creatinine 
clearance at 12 months after transplantation[9]. 
Narasimhamurthy et al studied 85 donors and found 
those with larger combined volumes were more likely 
and quickly to achieve eGFR values of 60 mL/min/ 
1.73 m2or more[10]. Results of the current study also 
showed that, recipients receiving larger corrected 
donated kidney volume ≥ 90 mm3 had better eGFR at 3 
and 6 months, though the difference was not seen at 9 
and 12 months post transplant . The most recent 
international guideline on living kidney donor and care 
recommends using  serum creatinine - based equations 
and then to confirm GFR via different techniques.[11] 
 
 Over the past decades, the selection criteria for living 
kidney donors has become more restrictive with the 
minimum baseline level of kidney function in living 
donors[12]. In this study, donated kidney GFR and 
eGFR of the recipients were analysed. To study the 
correlation, the patients were divided into group 1 ( n 
=17 ) having GFR < 40ml/ min / 1.73 m2 , group 2 ( n 
= 36 ) having donated kidney GFR ≥ 40 ml / min / 1.73 
m2. Recipients in group 2 had significantly higher GFR 
at 3 months ( 89 vs 75 ml/ min / 1.73 m2 ) and at 6 
months ( 86 vs 67 ml/ min / 1.73 m2). Lezaic et al 
studied 180 live kidney recipients with a functioning 
graft > 1 year with an aim to estimate the relationship 
between the single kidney GFR of the transplanted 
kidney with subsequent graft function. They assigned 
patients in group 1 to those, who received single 
kidney GFR < 50ml ( 32 patients) and group 2, to those 
who received single kidney GFR > 50 ml ( 38 patients). 
They found no correlation of single kidney GFR on the 
graft outcomes[13]. Our results though not entirely 
agree with Lezaic et al, still reflects the same findings 
that the donated kidney GFR though has impact at 3 
months and 6 months GFR of the recipient, but still 
fades at 9 and 12 months post transplant. In a study of 
344 live related renal transplantation by Norden et al, it 
was seen that graft survival was significantly decreased 
in recipients of graft from donor having low GFR[14]. 
In 2011, Brar et al showed that majority, that is 66% of 
centres used a cut-off value of GFR of > =  80 mL/ min 
for exclusion of living kidney donors[15]. Young et al 
compared the recipients of living donor kidneys with 
eGFR < 80ml/ min/ 1.73m2 to those ≥ 110 ml/ min / 
1.73m2 , followed them up to 6 years and found the 
hazard ratio for the outcome of graft loss to be 1.23( 
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95% Cl0.84-1.92, p= 0.26)[16]. Some centres used 
creatinine clearance as a measure of eGFR followed by 
isotopic clearance assay[17].In our study, we found 
that the donor mean eGFR ( MDRD ) and GFR done 
by 99m Tc-DTPA ( diethylenetriamine pentaacetic acid 
) were almost similar. Also mean eGFR and DTPA 
GFR of the donated kidney were similar. However, we 
didn’t find any statistically significant correlation 
between eGFR of the recipient and donor GFR as 
estimated by MDRD equation. This may be due to 
smaller study population in our study group. 
 
Conclusion  
 
The present study includes 53 donor- recipient pairs 
with mean age of the recipient being 34± 10.6 years, 
who underwent live kidney transplantation at our 
institution. The characteristics of the donated kidney 
was corrected donated kidney volume: 93 ± 22.7mm3, 
donated kidney GFR ( by DTPA) : of 47.86ml/ min and 
donated kidney eGFR ( by MDRD Equation): 49.27± 
12ml/min. Accordingly we concluded that recipients 
who received corrected kidney volume ≥ 90 mm3 had 
better renal function at 3 and 6 months post transplant. 
Similarly when the GFR of the donated kidney was 
≥40ml/ min, renal function at 3 and 6 months post 
transplant was significantly better. Donor age < 45 
years resulted in significantly better graft function at 12 
months post transplantation. So donor kidney size, 
donor GFR and age of the donor should be considered 
as predictive factors for graft outcome in living kidney 
transplantation.  
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